piperazine has been researched along with ferulic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fu, P; Liu, F; Xie, XS; Yin, JP; Zhou, L | 1 |
Fu, P; Li, J; Liu, F; Xie, XS; You, GQ | 1 |
Barik, A; Garg, P; Gupta, S; Jahan, S; Kamble, K; Kumar, N; Modi, G; Shankar, G; Singh, G; Singh, GK; Singh, L; Singh, YP; Tiwari, S; Upadhyay, P | 1 |
Gan, X; Hu, D; Liang, J; Liu, D; Wang, Z; Yuan, T; Zeng, H | 1 |
4 other study(ies) available for piperazine and ferulic acid
Article | Year |
---|---|
[Effects of piperazine ferulate on connective tissue growth factor and extracellular matrix in TGF-beta1 induced mesangial cells].
Topics: Animals; Cells, Cultured; Connective Tissue Growth Factor; Coumaric Acids; Extracellular Matrix; Glomerulosclerosis, Focal Segmental; Mesangial Cells; Piperazine; Piperazines; Rats; Transforming Growth Factor beta1 | 2008 |
[Effects of piperazine ferulate on TGF-beta1-induced renal interstitial fibroblast activation].
Topics: Actins; Animals; Cells, Cultured; Connective Tissue Growth Factor; Coumaric Acids; Fibroblasts; Fibrosis; Kidney; Piperazine; Piperazines; Rats; Transforming Growth Factor beta1 | 2008 |
Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biological Products; Biphenyl Compounds; Butyrylcholinesterase; Cholinesterase Inhibitors; Coumaric Acids; Dose-Response Relationship, Drug; Horses; Humans; Models, Molecular; Molecular Structure; Neuroprotective Agents; Picrates; Piperazine; Structure-Activity Relationship | 2021 |
Ferulic acid derivatives with piperazine moiety as potential antiviral agents.
Topics: Antiviral Agents; Coumaric Acids; Cucumovirus; Drug Design; Piperazine; Structure-Activity Relationship; Tobacco Mosaic Virus | 2022 |